Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Clinical trial NCT01431547 · COMPLETED
Trial details
- NCT number
- NCT01431547
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-09-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.